Immunogenicity and Efficacy of Recombinant RSV-F Vaccine in a Mouse Model

RSV vaccine development has constraints due to safety issues encountered by formalin inactivated FI-RSV vaccines. A desirable vaccine should induce Th(1) responses and a strong mucosal immunity to provide complete protection from RSV infection. In the present paper, we developed and evaluated a muco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Singh, Shree R., Dennis, Vida A., Carter, Christina L., Pillai, Shreekumar R., Jefferson, Ayanna, Sahi, Shivendra V., Moore, Eddie G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1986827/
https://ncbi.nlm.nih.gov/pubmed/17629376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2007.05.068
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados